Updated Jul 16, 2026
Hernday Natasha has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.

Hernday Natasha appears in SEC filing context related to XOMA Royalty Corp as of 2026-05-26. Public biographical information about this exact name is not readily available, and the role, background, or tenure of this individual within XOMA Royalty Corp is not disclosed in widely accessible sources. Name variations such as Natasha Hernday or N. Hernday could exist, but no confirmed details are publicly documented beyond the SEC context. If this name is listed in connection with the company, it could represent an insider, director, officer, or other affiliated party, but specifics are not verifiable from the provided context.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | XOMA | XOMA Royalty Corp | D — Derivative transaction | 4.0K | — | |
| 2026-07-15 | XOMA | XOMA Royalty Corp | J — Other acquisition / disposition | 9.3K | — | |
| 2026-06-13 | JANX | Janux Therapeutics, Inc. | A — Grant or award | 5.5K | $0.00 | |
| 2026-05-26 | XOMA | XOMA Royalty Corp | A — Grant or award | 3.6K | $0.00 |
Hernday Natasha appears in SEC filing context related to XOMA Royalty Corp as of 2026-05-26. Public biographical information about this exact name is not readily available, and the role, background, or tenure of this individual within XOMA Royalty Corp is not disclosed in widely accessible sources. Name variations such as Natasha Hernday or N. Hernday could exist, but no confir…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hernday Natasha profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.